Insider · CIK 0001613867
Behbahani Ali
Positions
- Black Diamond Therapeutics, Inc. · BDTX(6 filings)
- Korro Bio, Inc. · KRRO(2 filings)
- SpyGlass Pharma, Inc. · SGP(3 filings)
- Trevi Therapeutics, Inc. · TRVI(1 filing)
- NeueHealth, Inc. · NEUE(1 filing)
- Adaptimmune Therapeutics PLC · ADAP(1 filing)
- Arcellx, Inc. · ACLX(2 filings)
- Monte Rosa Therapeutics, Inc. · GLUE(1 filing)
- CRISPR Therapeutics AG · CRSP(1 filing)
- Nkarta, Inc. · NKTX(1 filing)
Recent Filings (19)
- Form 4Black Diamond Therapeutics, Inc.+6,919 sh
- Form 4Korro Bio, Inc.+450,045 sh
- Form 5Trevi Therapeutics, Inc.
- Form 4SpyGlass Pharma, Inc.+937,500 sh
- Form 4SpyGlass Pharma, Inc.+27,400 sh
- Form 3SpyGlass Pharma, Inc.
- Form 4Black Diamond Therapeutics, Inc.+5,208 sh
- Form 4NeueHealth, Inc.-3,879,266 sh
- Form 4Black Diamond Therapeutics, Inc.+4,291 sh
- Form 4Adaptimmune Therapeutics PLC-19,500,000 sh
- Form 4Arcellx, Inc.+4,207 sh
- Form 4Black Diamond Therapeutics, Inc.+6,170 sh
- Form 4Monte Rosa Therapeutics, Inc.+30,700 sh
- Form 4Black Diamond Therapeutics, Inc.+30,550 sh
- Form 4Korro Bio, Inc.+6,010 sh
- Form 4Nkarta, Inc.+46,000 sh
- Form 4CRISPR Therapeutics AG+13,000 sh
- Form 4Arcellx, Inc.+9,174 sh
- Form 4Black Diamond Therapeutics, Inc.+7,646 sh